Phase 2a trial of atebimetinib + mGnP in first-line pancreatic cancer patients, well above the standard of care benchmark from GnP of 35% overall survival; On track for expanded pancreatic cancer ...

随着年龄的增长，我们的身体都会发生这样那样的变化，而肌肉力量的逐渐下降，是对影响老年人生命质量的重要方面。研究显示，人体肌肉的力量、质量在40岁左右就会开始下降，在50岁后则会逐渐加速，终生 肌肉量 损伤高达20%到30%，肌力损伤更是高达50%，特别是在65岁以后，身体功能下降更快。

Phase 2a trial of atebimetinib + mGnP in first-line pancreatic cancer patients, well above the standard of care benchmark from GnP of 35% overall ...